NKGen Biotech, Inc. Reports Third Quarter 2023 Financial
– SNK01 Phase I autologous clinical program demonstrated improvement in neuroinflammation and cognitive function in patients with Alzheimer’s Disease,...
Source: globenewswire.com
Graf Acquisition News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Graf Acquisition. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Graf Acquisition Today - Breaking & Trending Today
Why Orchard Therapeutics Shares Are Trading Higher By Around 95%; Here Are 20 Stocks Moving Premarket
Gainers Orchard Therapeutics plc (NASDAQ:ORTX) shares rose 95.5% to $15.80 in pre-market trading after the company inked a deal with Kyowa Kiri...
Source: businessinsider.com
Why Accolade Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session - Grupo Aeroportuario (NYSE:ASR), Accolade (NASDAQ:ACCD)
Gainers Orchard Therapeutics plc (NASDAQ: ORTX) shares climbed 97.7% to $15.98 after the company agreed to be acquired by Japan's Kyowa Kirin for $16.00 per ADS in cash plus an additional contingent value right of $1.00 per ADS.
Source: benzinga.com
Graf Acquisition IV : Unaudited Condensed Consolidated Financial Statements - Form 8-K -October 05, 2023 at 05:16 pm EDT
Unaudited Condensed Consolidated Financial Statements Condensed Balance Sheets as of June 30, 2023 ...
Source: marketscreener.com
Graf Acquisition Corp. IV Announces Adjournment of Special Meeting to Approve Business Combination with NKGen Biotech, Inc. to September 25, 2023
THE WOODLANDS, Texas, Sept. 22, 2023 /PRNewswire/ -- Graf Acquisition Corp. IV , announced today that on September 20, 2023, it adjourned, without conducting any business, the special meeting of...
Source: marketscreener.com